Altimmune is a clinical-stage biopharmaceutical company focused on developing next-generation peptide-based therapeutics. It is developing pemvidutide, a GLP-1/glucagon dual receptor agonist for the treatment of obesity and MASH.
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.